Deborah Jean Anderson, PhD, professor of medicine at Boston University School of Medicine (BUSM), received a four-year, $7.2 million grant from the NIH National Institute of Child Health and Human Development renewing its support for a Contraception Research Center (CRC) at BUSM to continue its research to develop innovative contraceptive products based on monoclonal antibodies (mAb) and multipurpose prevention technology (MPT).
This research has the potential to improve the lives of millions of women around the world by addressing two simultaneous reproductive health crises: an unacceptably high rate of unintended pregnancies in developing and developed countries and an epidemic of infections. sexually transmitted. »
Deborah Jean Anderson, PhD, professor of medicine at Boston University School of Medicine
With prior funding from National Institute of Allergy and Infectious Diseases, Anderson and his team has developed a vaginal film containing mAbs against HIV-1 and HSV-2 (herpes simplex virus type 2) that has been shown to be safe and effective in a phase 1 clinical trial, and recently, thanks to the funding for his first CRC grant, Anderson developed an antisperm antibody for contraception. With this new award, Anderson plans to advance these products through advanced clinical trials.
For the past 40 years, Anderson has led a research laboratory that studies reproductive health, mucosal immunology, and sexual transmission of HIV. His laboratory was among the first to study the immunological causes of infertility and to identify risk factors for HIV transmission.
Boston University School of Medicine